Physicians' Academy for Cardiovascular Education

Surviving elevated Lp(a): a patient story from diagnosis to treatment

10' education - May 27, 2016 - Innsbruck, Germany - Sandra Revill Tremulis, MBA - FRIDAY, MAY 27, 2016, lunch symposium at Lp(a) symposium prior to EAS

Video navigation menu

  • The personal story of the founder of the Lipoprotein(a) Foundation 0:01
  • The Lipoprotein(a) Foundation - aiming to identify individuals with elevated Lp(a) 4:36
  • Objectives of the foundation: advocacy, community education and patient support 6:49
  • Setting up a registry: the Lp(a) Foundation Patient Natural History Study 7:52

Disclosures

Sandra Revill Tremulis is the Founder of the Lipoprotein(a) Foundation, with the vision to live in a world where elevated Lp(a) is routinely diagnosed, treated and family screened.

There is currently no treatment for high Lp(a). The foundation has a long way to go, but they are starting the conversation about inherited premature cardiovascular disease due to high Lipoprotein(a). Sandra does not want anyone to experience the tragic loss of a family member. She wants the research data -- and a treatment -- to be in place to help her daughter and all those children who have a high risk of inheriting elevated Lp(a) from their parents, to protect them from these serious and tragic risks.

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.